Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pediatric Exclusivity May Overcompensate Blockbuster Products – JAMA Study

Executive Summary

The net economic return to companies granted pediatric exclusivity ranged from $8.9 million to $507 million, researchers found in a study of the economic impact of the pediatric exclusivity program
Advertisement

Related Content

Pediatric Exclusivity 90-Day Review Can Be “Difficult” Target – Kweder
Pediatric Exclusivity 90-Day Review Can Be “Difficult” Target – Kweder
Pediatric Studies Become Costlier; Congress May Make Them Less Profitable
Pediatric Studies Become Costlier; Congress May Make Them Less Profitable
Advertisement
UsernamePublicRestriction

Register

PS048023

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel